| VTRS |
Report |
China Revenue (Q2 2026) |
BEAT |
pred ~$650M vs. cons $617M |
MEDIUM |
| VTRS |
Report |
Adj. EBITDA (Q2 2026) |
BEAT |
pred ~$1,095M vs. cons $1,079M |
MEDIUM |
| VTRS |
Report |
Total Revenue (Q2 2026) |
BEAT |
pred ~$3,720M vs. cons $3,677M |
MEDIUM |
| VTRS |
Guide |
FY 2026 Revenue (FY 2026) |
UNCHANGED |
guide ~$14.6-14.8B vs. cons $14,802M |
HIGH |
| VTRS |
Guide |
FY 2026 Adj. EBITDA (FY 2026) |
UNCHANGED |
guide ~$4.3-4.4B vs. cons $4,386M |
HIGH |
| VTRS |
Guide |
FY 2026 Adj. EPS (FY 2026) |
UNCHANGED |
guide ~$2.40-2.50 vs. cons $2.454 |
HIGH |
| VTRS |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.5% |
— |
MEDIUM |
| VTRS |
Return |
5-day cumulative residual |
+3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — H2 math coherent, no forced estimate cuts; short covering provides a bid; absent a formal raise, momentum fades modestly from day-1 |
MEDIUM |